BAX Baxter International Inc.
Healthcare
Price
$27.68
Intrinsic value
$2.81
Buy price
$2.25
Discount
-883.5%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $1,319,000,000.00
- Total debt
- $9,667,000,320.00
- Cash & STI
- $2,150,000,128.00
- Shares out.
- 518,000,000
Overvalued [LOW CF reliability]
Intrinsic value$2.81
Buy price (with MOS)$2.25
Current price$27.68
Discount to intrinsic value-883.7%
7-step quality scorecard
ROE quality
LOW- Average ROE
- -8.8%
- Current ROE
- -15.6%
- Minimum ROE
- -41.7%
Debt quality
LEVERAGED- Debt / Equity
- 1.58x
Moat proxy
MODERATE_PROXYCash-flow reliability
LOW- Operating CF / Net income
- —
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 107.8%
- Public economic interest
- 100.4%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.